Effect of nociceptin on histamine and serotonin release in the central nervous system;A nociceptin hatása a hisztamin és szerotonin kiáramlásra a központi idegrendszerben

Acta Pharmaceutica Hungarica

Volumn 76, Issue 3, 2006, Pages 127-132

  Gyenge, Melinda ^a   Hantos, Mónika ^b   Laufer, Rudolf ^a   Tekes, Kornélia ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet ^*  (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; NOCICEPTIN; SEROTONIN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DEGRANULATION; HIPPOCAMPUS; HYPOTHALAMUS; MAST CELL; NERVE CELL; NOCICEPTION; PLASMA;

ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HISTAMINE; HISTAMINE RELEASE; HYPOTHALAMUS; PAIN; RATS; RATS, WISTAR; SEROTONIN; SUBSTANCE P;

EID: 33749495048     PISSN: 00016659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Henderson, G., and McKnight, A. T.: The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. TIPS., 18, 293-300 (1997).
2. Reinscheid, R. K., Nothacker, H. P., Bourson, A. et al.: Orphanin FQ a neuropeptid that activates an opioidlike G protein-coupled receptor. Science, 270, 792-794 (1995).
3. Meunier, J. C., Mollereau, C., Toll, L. et al.: Isolation and structure of endogenous agonist of opioid receptor-like ORL1 receptor, Nature, 377, 532-534 (1995).
4. Calo, G., Guerrini, R., Rizzi, A., Salvadori, S., Regoli, D.: Pharmacology of nociceptin and its receptor: a novel therapeutic target. Brit. J. Pharmacol., 129, 1261-1283 (2000).
5. Mogil, J. S., Pasternak, G. W.: The molecular and behavioral pharmacology of the Orphanin FQ/Nociceptin peptide and receptor family. Pharm. Rev., 53, 381-415 (2001).
6. Sbrenna, S., Marti, M., Morari, M., et al.: Modulation of 5-hydroxitriptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Brit J. Pharmacol., 130, 425-433 (2002).
7. Eriksson, K. S., Stevens, D. R., Haas, H. L.: Opposite modulation of histaminergic neurons by nociceptin and morphine. Neuropharmacology, 39, 2492-2498 (2000).
8. Malmberg-Aiello, P., Lamberti, C., Giotti, A., Ghelandini, C., Bartolini, A.: Role of histamine in antinociception. Brit J. Pharmacol., 111, 1269-79 (1994).
9. Darland, T., Heinricher, M. M., Grandy, D. K.: Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. TINS, 21, 215-21 (1998).
10. Németh, J., Helyes, Z., Oroszi, G.: Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats. Eur. J. Pharmacol., 347, 101-104 (1998).
11. Kimura, T., Kitaichi, K., Hiramatsu, K., Yoshida, M., Ito, Y., Kuma, H., et al.: Intradermal application of nociceptin increases vascular permeability in rats: the possible involvement of histamine release from mast cells. Eur. J. Pharmacol., 407, 327-32 (2000).
12. Tekes, K., Hantos, M., Bizderi, B., Gyenge, M., Kecskemeti, V., Huszti, Z.: Stimulating effect of nociceptin on histamine release in the rat brain? Inflamm. Res., 54, 38-39 (2005).
13. Taylor, K. M., Snyder S. H.: Isotopic microassay of histamine, histidine, histidine decarboxylase and histamine methyl transferase in brain tissue. J. Neurochem., 19, 1343-58 (1972).
14. Morgadinho, M. T., Fontes Ribeiro, C. A., Macedo T. R. A.: Influence of the sample preparation method on the serotonin determination in plasma and platelets. Biomed. Chromatogr., 18, 739-744 (2004).
15. Brown, D., Tomchick, R., Axelrod, J.: The distribution and properties of HNMT. J.B.C. 234, 2948 (1954) (a módszer módosítása: Swartz J. C., Brain Res., 118, 509 (1976).
16. Lowry, O., Rosebrough, N., Farr, A., Randall, R.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-75 (1951).